Related Experiment Videos
Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy
K Güven1, F Kelestimur, M Yücesoy
1Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey.
The European Journal of Medicine
|February 1, 1993
Summary
Low triiodothyronine (T3) and albumin levels in non-alcoholic cirrhotic patients indicate a higher risk of hepatic encephalopathy and poor prognosis. Thyroid function tests can serve as valuable prognostic indicators for acute outcomes.
Area of Science:
- Hepatology
- Endocrinology
- Clinical Biochemistry
Background:
- Non-alcoholic cirrhosis is a severe liver condition.
- Hepatic encephalopathy (HE) is a serious complication of cirrhosis.
- Thyroid dysfunction is common in liver disease.
Purpose of the Study:
- To investigate thyroid hormone level changes in cirrhotic patients with HE.
- To determine if thyroid function tests can predict acute outcomes in HE patients.
Main Methods:
- Studied cirrhotic patients with and without HE, divided into survivors and non-survivors.
- Measured serum levels of triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), free T3 (FT3), and free T4 (FT4).
- Evaluated the relationship between thyroid function test alterations and acute outcomes.
Main Results:
- Serum T3 and FT3 levels were significantly lower in non-survivors compared to controls (p < 0.05).
- Serum FT3 and FT4 levels were lower in survivors compared to cirrhotic controls (p < 0.05).
- Serum albumin was identified as the most significant prognostic factor (p < 0.05).
Conclusions:
- Low FT3 levels indicate a high risk for HE in non-alcoholic cirrhotic patients.
- Decreased serum T3 and albumin levels are indicators of poor prognosis for acute outcomes in HE.
- Thyroid function tests, particularly FT3, show potential as prognostic markers for HE.